View Post

Important Patient-Provider Conversations in the Metastatic Breast Cancer Space

In In The News by Barbara Jacoby

By: BRIELLE BENYON From: The landscape of metastatic hormone receptor (HR)-positive breast cancer continues to evolve, highlighting the necessity of genetic and genomic testing, explained Elisa Krill-Jackson, MD. In a recent interview with Oncology Nursing News, Krill-Jackson, a breast medical oncologist at the University of Miami Sylvester Comprehensive Cancer Center, discussed these changes, as well as the important conversations …